News

When & Where: Shadow Summit – Monday, July 21 from 10 a.m. to 4:30 p.m. Hidden Valley Resort (next door to the Deerhurst Resort where the Premiers are meeting) 1755 Valley Rd, Huntsville, ON P1H 1A8 ...
Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced new data for its AI-enabled Heartflow Plaque Analysis, including final primary endpoint data from the ...
Published regularly in French and English, the Newsletter will be available in the “Investors” section of the OSE Immunotherapeutics website. To subscribe to receive our Newsletters: ...
This release has been authorised by the directors of Immuron Limited. Steven Lydeamore Chief Executive Officer ...
Clinical data from the OT‑101 P001 PDAC study suggest that targeting TGFB2 merits additional evaluation in younger patients; in a treated subset characterized by low IL‑6, median OS was 12.7 months. † ...
Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced the signing of a letter of intent to lease a 17,428-square-foot facility in New Jersey. The facility, formerly ...
Liv Hospital has signed a strategic collaboration agreement with the University of Pennsylvania (UPenn), the institution where CAR-T therapy was originally developed. This partnership allows Liv to ...
CHICAGO, July 17, 2025 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) today announced that, following rigorous review, Professional Credit has once again achieved the “Peer ...
The SPRINT PNS System is indicated for up to 60 days for: Symptomatic relief of chronic, intractable pain, post-surgical and post-traumatic acute pain; symptomatic relief of post-traumatic pain; ...
Jennifer B. Brooke Valerin, Jacob Thomas, J. Eva E. Selfridge, Madison Conces, Devalingam Mahalingam, Michael Cecchini, Elena G. Chiorean, Oana Danciu, Kyechin Chen, Ana Paula G. Cugnetti, Judith ...
Castle earns recognition as a national Healthcare Industry Top Workplace, an Arizona Top Workplace and receives five Top Workplaces Culture Excellence awards ...
Separately, BioStem remains actively engaged in its Form 10 filing process and will provide additional updates on its planned Nasdaq uplisting during its second quarter 2025 earnings call.